185 related articles for article (PubMed ID: 28397790)
1. Evaluation of Tumor Treatment of Magnetic Nanoparticles Driven by Extremely Low Frequency Magnetic Field.
Li W; Liu Y; Qian Z; Yang Y
Sci Rep; 2017 Apr; 7():46287. PubMed ID: 28397790
[TBL] [Abstract][Full Text] [Related]
2. Effect of low frequency magnetic fields on the growth of MNP-treated HT29 colon cancer cells.
Spyridopoulou K; Makridis A; Maniotis N; Karypidou N; Myrovali E; Samaras T; Angelakeris M; Chlichlia K; Kalogirou O
Nanotechnology; 2018 Apr; 29(17):175101. PubMed ID: 29498936
[TBL] [Abstract][Full Text] [Related]
3. Magnetic nano-Fe3O4 particles targeted gathering and bio-effects on nude mice loading human hepatoma Bel-7402 cell lines model under external magnetic field exposure in vivo.
Chen Z; Wen J; Ju H; Fang Z
Electromagn Biol Med; 2015; 34(4):309-16. PubMed ID: 24856871
[TBL] [Abstract][Full Text] [Related]
4. Apoptosis selectively induced in BEL-7402 cells by folic acid-modified magnetic nanoparticles combined with 100 Hz magnetic field.
Wen J; Jiang S; Chen Z; Zhao W; Yi Y; Yang R; Chen B
Int J Nanomedicine; 2014; 9():2043-50. PubMed ID: 24790442
[TBL] [Abstract][Full Text] [Related]
5. Multifunctional mitoxantrone-conjugated magnetic nanosystem for targeted therapy of folate receptor-overexpressing malignant cells.
Barar J; Kafil V; Majd MH; Barzegari A; Khani S; Johari-Ahar M; Asgari D; Coukos G; Omidi Y
J Nanobiotechnology; 2015 Mar; 13():26. PubMed ID: 25880772
[TBL] [Abstract][Full Text] [Related]
6. Embryological changes induced by weak, extremely low frequency electromagnetic fields.
Delgado JM; Leal J; Monteagudo JL; Gracia MG
J Anat; 1982 May; 134(Pt 3):533-51. PubMed ID: 7107514
[TBL] [Abstract][Full Text] [Related]
7. Mesoporous γ-Iron Oxide Nanoparticles for Magnetically Triggered Release of Doxorubicin and Hyperthermia Treatment.
Benyettou F; Ocadiz Flores JA; Ravaux F; Rezgui R; Jouiad M; Nehme SI; Parsapur RK; Olsen JC; Selvam P; Trabolsi A
Chemistry; 2016 Nov; 22(47):17020-17028. PubMed ID: 27739116
[TBL] [Abstract][Full Text] [Related]
8. Biosynthesis, characterization of magnetic iron oxide nanoparticles and evaluations of the cytotoxicity and DNA damage of human breast carcinoma cell lines.
Sulaiman GM; Tawfeeq AT; Naji AS
Artif Cells Nanomed Biotechnol; 2018 Sep; 46(6):1215-1229. PubMed ID: 28826240
[TBL] [Abstract][Full Text] [Related]
9. Improving antiproliferative effect of the anticancer drug cytarabine on human promyelocytic leukemia cells by coating on Fe3O4@SiO2 nanoparticles.
Shahabadi N; Falsafi M; Mansouri K
Colloids Surf B Biointerfaces; 2016 May; 141():213-222. PubMed ID: 26852105
[TBL] [Abstract][Full Text] [Related]
10. Probing mucin interaction behavior of magnetic nanoparticles.
Boya VN; Lovett R; Setua S; Gandhi V; Nagesh PKB; Khan S; Jaggi M; Yallapu MM; Chauhan SC
J Colloid Interface Sci; 2017 Feb; 488():258-268. PubMed ID: 27837716
[TBL] [Abstract][Full Text] [Related]
11. Long-circulating PEGylated manganese ferrite nanoparticles for MRI-based molecular imaging.
Pernia Leal M; Rivera-Fernández S; Franco JM; Pozo D; de la Fuente JM; García-Martín ML
Nanoscale; 2015 Feb; 7(5):2050-9. PubMed ID: 25554363
[TBL] [Abstract][Full Text] [Related]
12. Multistimuli-Regulated Photochemothermal Cancer Therapy Remotely Controlled via Fe5C2 Nanoparticles.
Yu J; Ju Y; Zhao L; Chu X; Yang W; Tian Y; Sheng F; Lin J; Liu F; Dong Y; Hou Y
ACS Nano; 2016 Jan; 10(1):159-69. PubMed ID: 26602632
[TBL] [Abstract][Full Text] [Related]
13. The efficiency of magnetic hyperthermia and in vivo histocompatibility for human-like collagen protein-coated magnetic nanoparticles.
Chang L; Liu XL; Di Fan D; Miao YQ; Zhang H; Ma HP; Liu QY; Ma P; Xue WM; Luo YE; Fan HM
Int J Nanomedicine; 2016; 11():1175-85. PubMed ID: 27042065
[TBL] [Abstract][Full Text] [Related]
14. A facile microwave synthetic route for ferrite nanoparticles with direct impact in magnetic particle hyperthermia.
Makridis A; Chatzitheodorou I; Topouridou K; Yavropoulou MP; Angelakeris M; Dendrinou-Samara C
Mater Sci Eng C Mater Biol Appl; 2016 Jun; 63():663-70. PubMed ID: 27040263
[TBL] [Abstract][Full Text] [Related]
15. Epidermal growth factor (EGF) fragment-guided anticancer theranostic particles for pH-responsive release of doxorubicin.
Kang MK; Mao W; Lee JB; Yoo HS
Int J Pharm; 2017 Mar; 519(1-2):104-112. PubMed ID: 28087384
[TBL] [Abstract][Full Text] [Related]
16. A systematic study of transfection efficiency and cytotoxicity in HeLa cells using iron oxide nanoparticles prepared with organic and inorganic bases.
Calmon MF; de Souza AT; Candido NM; Raposo MI; Taboga S; Rahal P; Nery JG
Colloids Surf B Biointerfaces; 2012 Dec; 100():177-84. PubMed ID: 22766295
[TBL] [Abstract][Full Text] [Related]
17. Preparation of lysine-coated magnetic Fe2O3 nanoparticles and influence on viability of A549 lung cancer cells.
Ma YH; Peng HY; Yang RX; Ni F
Asian Pac J Cancer Prev; 2014; 15(20):8981-5. PubMed ID: 25374240
[TBL] [Abstract][Full Text] [Related]
18. Magnetic nickel ferrite nanoparticles: Green synthesis by Urtica and therapeutic effect of frequency magnetic field on creating cytotoxic response in neural cell lines.
Amiri M; Pardakhti A; Ahmadi-Zeidabadi M; Akbari A; Salavati-Niasari M
Colloids Surf B Biointerfaces; 2018 Dec; 172():244-253. PubMed ID: 30173091
[TBL] [Abstract][Full Text] [Related]
19. A comparison inhibitory effects of cisplatin and MNPs-PEG-cisplatin on the adhesion capacity of bone metastatic breast cancer.
Mokhtari MJ; Koohpeima F; Mohammadi H
Chem Biol Drug Des; 2017 Oct; 90(4):618-628. PubMed ID: 28338288
[TBL] [Abstract][Full Text] [Related]
20. Magnetic nanoparticles for drug targeting: from design to insights into systemic toxicity. Preclinical evaluation of hematological, vascular and neurobehavioral toxicology.
Agotegaray MA; Campelo AE; Zysler RD; Gumilar F; Bras C; Gandini A; Minetti A; Massheimer VL; Lassalle VL
Biomater Sci; 2017 Mar; 5(4):772-783. PubMed ID: 28256646
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
